期刊文献+

冠状动脉粥样硬化性心脏病合并2型糖尿病患者血清Lp-PLA2水平与颈动脉内膜中层厚度的关系 被引量:6

Correlation of serum Lp-PLA2, carotid artery intima mesia thickness in patients with both coronary heart disease and type 2 diabetes
下载PDF
导出
摘要 目的 :探讨冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease,CHD)合并2型糖尿病(type2 diabetes,T2DM)患者血清脂蛋白磷脂酶A2(lipoprotein-associated phospholipase A2,Lp-PLA2)及颈动脉内膜中层厚度(intima mesia thickness,IMT)的关系。方法 :选择2014年1月—2015年6月期间在南通大学附属医院住院治疗的CHD合并T2DM患者70例作为观察组,同期入院的T2DM患者65例作为对照组,采用酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测血清Lp-PLA2,颈动脉彩色多普勒超声检测颈动脉IMT。比较两组患者的血清LpPLA2、颈动脉IMT、血脂及糖化血红蛋白水平,并分析CHD合并T2DM患者血清Lp-PLA2水平与颈动脉IMT的关系。结果:观察组的Lp-PLA2水平和颈动脉IMT均高于对照组(P<0.01),观察组患者颈动脉IMT与血清Lp-PLA2呈正相关(r=0.724,P=0.000)。结论 :CHD合并T2DM患者血清LP-PLA2水平显著增高,与动脉粥样硬化密切相关。 Objective: To investigate the correlation of serum lipoprotein-associated phospholipase A2(Lp-PLA2), carotid artery intima mesia thickness(IMT) in patients with both coronary heart atherosclerotic disease(CHD) and type 2 diabetes(T2DM). Methods: Seventy cases of patients with CHD and T2 DM diagnosed and treated in the Affiliated Hospital of Nantong University from January 2014 to June 2015 were used as the observation group,whereas another 65 cases of T2 DM patients without CHD that were treated in the same hospital in the same period were used as control group. Serum Lp-PLA2 level and carotid artery IMT were detected by ELISA and carotid artery color Doppler ultrasound, respectively. The serum levels of LpPLA2, carotid artery IMT, blood lipid and glycosylated hemoglobin were compared between the two groups, and the relationship between serum Lp-PLA2 level and carotid IMT in patients with coronary heart disease and T2 DM were analyzed.Results: Lp-PLA2 level and IMT of patients in the observation group was significantly higher than that of patients in the control group,the carotid artery IMT in CHD patients was positively correlated to serum Lp-PLA2 level( r=0.724,P=0.000).Conclusion: Serum Lp-PLA2 levels in patients with CHD complicated with T2 DM were significantly higher, which was closely related to atherosclerosis.
出处 《南通大学学报(医学版)》 2015年第6期522-525,共4页 Journal of Nantong University(Medical sciences)
基金 南通市科技局社会事业科技创新项目(S11954) 十二五国家科技支撑计划(2011BAI11B07)
关键词 冠状动脉粥样硬化性心脏病 2型糖尿病 血清脂蛋白磷脂酶A2 颈动脉内膜中层厚度 coronary atherosclerotic heart disease type 2 diabetes lipoprotein-associated phospholipase A2 carotid artery intima mesia thickness
  • 相关文献

参考文献13

  • 1Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecast- ing the future of cardiovascular disease in the United States a policy statement from the American heart associa- tion[J]. Circulation, 2011, 123(8):933-944.
  • 2Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evi- dence from a comprehensive network meta-analysis [J]. Lancet, 2012, 379(9824):1393-1402.
  • 3张灿,陈炎,朱秀龙,胡彩莲,莫观海,邱国,梁锦锋,冯燊龙.血浆脂蛋白相关磷脂酶A2活性与冠脉病变程度和冠心病的关系分析[J].中国医药导报,2014,11(16):45-47. 被引量:4
  • 4杨琴.血浆脂蛋白相关磷脂酶A2检测在冠状动脉粥样硬化中的应用价值[J].西部医学,2013,25(5):784-785. 被引量:18
  • 5Epps KC, Wilensky RL. Lp-PLA2-a novel risk factor for high-risk coronary and carotid artery disease[J]. J Intern Med, 2011, 269(1):94-106.
  • 6陈灏珠.内科学[M].8版.北京:人民卫生出版社,2002:47.
  • 7Macphee CH, Moores KE, Boyd I-IF, et al. Lipoprotein-as- sociated phospholipase A2, platelet-activating factor acety|- hydrolase, generates two bioactive products during the oxi-dation of low-density lipoprotein: use of a novel inhibitor[J]. Biochem J, 1999, 338(Pt 2):479-487.
  • 8Ikonomidis I, Michalakeas CA, Lekakis J, et al. The role of lipoprotein-associated phospholipase A2(Lp-PLA2) in car- diovascular disease[J]. Rev Recent Clin Trials, 2011, 6(2): 108-113.
  • 9Hakkinen T, Luoma JS, Hiltunen MO, et al. Lipoprotein- associated phospholipase A(2), platelet-activating factor ace tylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions[J]. Arterioscler Thromb Vase Biol, 1999, 19(12):2909-2917.
  • 10Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2006, 26(11):2523-2529.

二级参考文献38

  • 1陶寿淇.中国的冠心病预防[J].中国慢性病预防与控制,1992(1):10-11. 被引量:17
  • 2黄从新.PwV和ABI检测临床应用的研究进展.心血管网特刊,2007,8.
  • 3Dadu RT, Nambi V, Ballantyne CM. Developing and assessingcardiovascular biomarkers[J], Transl Res, 2012, 159 (4) : 265-276.
  • 4Hansson GK. Inflammation, atherosclerosis, and coronary ar-tery disease[J]. N Engl J Med, 2005,352(16) :1685-1695.
  • 5Colley KJ, Wolfert RL. Cobble ME. Lipoprotein associatedphospholipase A(2) : role in atherosclerosis and utility as a bio-marker for cardiovascular risk[J], EpmaJ,2011 .2(1) :27-38.
  • 6Ferguson JFt Hinkle CC, Mehta NN. etal. Translational stud-ies of lipoprotein-associated phospholipase A2 in inflammationand atherosclerosisCJ]. J Am Coll Cardiol. 2012,59(8) :764.
  • 7Rubinstein A. Izkhakov E. Lipoprotein associated phospholipaseA2[J]. Harefuah, 2011,150(2):136-140, 205.
  • 8Gilstrap LG, Wang TJ. Biomarkers and cardiovascular risk as-sessment for primary prevention: an update [J]. Clin Chem,2012,58(1):72-82.
  • 9Oei HH, van der Meer IM, Hofman A. Lipoprotein-associatedphospholipase A2 activity is associated with risk of coronaryheart disease and ischemic stroke : the Rotterdam Study[J]. Cir-culation,2005,111(5) *570-575.
  • 10Libby P. Inflammation in atherosclerosis[J], Nature, 2002,420(6917):868-874.

共引文献63

同被引文献43

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部